Clinical trial
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell…
NCT00480389 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00480389 |
|---|---|
| Title | Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal |
| Official title | Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Cell Carcinoma, Metastatic Disease |
| Intervention type | Drug |
| Interventions | Sorafenib |
| Enrollment | 19 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2012 |
| Completion | Mar 1, 2013 |
| First posted | May 30, 2007 |
| Last update posted | Dec 9, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: